HOW is the landscape evolving for biosimilar medicines?
By 2008-2012 will see further developments in relation to biosimilar medicines, and healthcare professionals and healthcare purchasers need to ensure that they are aware of what is happening in this rapidly changing environment. The patent protection on a large number of originator reference products has expired since 2001, which would lead to expect a growing number of biosimilar products on the market in the not too distant future.
2007-2010 will see further developments in relation to biosimilar medicines, and healthcare professionals and healthcare purchasers need to ensure that they are aware of what is happening in this rapidly changing environment. The patent protection on a large number of originator reference products has expired since 2001, which would lead to expect a growing number of biosimilar products on the market in the not too distant future.
